Home Healthcare Inflation Is Stubbornly High -- WSJ
Accelerate Diagnostics | 8-K: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
Accelerate Q4 Revenue Of $11.7 Vs $12.1M YoY, $16.3M Cash Ending 2024; 3% Rise In Consumable Revenue Amid Pheno Capital Sales Decline
Accelerate Diagnostics Sees 2024 Rev $11.7M >AXDX
Press Release: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
Earnings Call Summary | Accelerate Diagnostics(AXDX.US) Q3 2024 Earnings Conference
Accelerate Diagnostics Resumed With a Buy at BTIG
Tuesday's Top Insider Moves: Execs Buy and Sell Big in US Stocks
Insider Purchase: Director at $AXDX (AXDX) Buys 200,000 Shares
Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript Summary
Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
Accelerate Diagnostics Reports Key Advances Amid Financial Challenges
Accelerate Diagnostics | 10-Q: Q3 2024 Earnings Report
Accelerate Diagnostics GAAP EPS of -$0.59 Misses by $0.12, Revenue of $2.98M Misses by $0.02M
Accelerate Diagnostics: Q3 Earnings Snapshot
Accelerate Diagnostics | 8-K: Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
Express News | Accelerate Diagnostics Q3 Net Income USD -14.6 Million
Accelerate Diagnostics 3Q Sales $2.98M >AXDX
Earnings Preview: AXDX to Report Financial Results Post-market on November 07
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results